Position in INCY
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$82,166
+$28,227 QoQ
Shares Held
873
+37.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MATHER GROUP, LLC. holds $3,197,722 across 30 Biotechnology names. INCY ranks #4 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,438 | $1,981,744 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
581 | $448,903 | |
| 3 | MRNA |
Moderna, Inc.
|
7,645 | $388,366 | |
| 4 | INCY |
Incyte Corp
This page
|
873 | $82,166 | |
| 5 | ARGX |
Argenx SE
|
68 | $49,657 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
73 | $38,213 | |
| 7 | INVA |
Innoviva, Inc.
|
1,500 | $34,950 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
410 | $30,786 |
All Filings in INCY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,166 | 873 | Shares | Sole | 2026-04-13 | |
| 2025-09-30 | $53,939 | 636 | Shares | Sole | 2025-10-21 | |
| 2025-03-31 | $34,816 | 575 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $57,189 | 828 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $43,295 | 655 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $132,636 | 2,188 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $48,937 | 859 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||